Avanos Medical (AVNS) Competitors $11.75 -0.08 (-0.68%) As of 02:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVNS vs. EYE, AORT, LMAT, LQDA, SSII, PRCT, ENOV, CDRE, NVCR, and CNMDShould you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include National Vision (EYE), Artivion (AORT), LeMaitre Vascular (LMAT), Liquidia Technologies (LQDA), SS Innovations International (SSII), PROCEPT BioRobotics (PRCT), Enovis (ENOV), Cadre (CDRE), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. Avanos Medical vs. Its Competitors National Vision Artivion LeMaitre Vascular Liquidia Technologies SS Innovations International PROCEPT BioRobotics Enovis Cadre NovoCure CONMED National Vision (NASDAQ:EYE) and Avanos Medical (NYSE:AVNS) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations. Is EYE or AVNS more profitable? National Vision has a net margin of -0.75% compared to Avanos Medical's net margin of -66.89%. Avanos Medical's return on equity of 6.16% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets National Vision-0.75% 3.56% 1.49% Avanos Medical -66.89%6.16%4.57% Do analysts prefer EYE or AVNS? National Vision currently has a consensus price target of $24.73, suggesting a potential downside of 3.78%. Given National Vision's stronger consensus rating and higher probable upside, research analysts plainly believe National Vision is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 1 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.45Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Which has more risk & volatility, EYE or AVNS? National Vision has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Does the media prefer EYE or AVNS? In the previous week, National Vision had 3 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for National Vision and 3 mentions for Avanos Medical. National Vision's average media sentiment score of 1.22 beat Avanos Medical's score of 0.00 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of EYE or AVNS? 95.2% of Avanos Medical shares are owned by institutional investors. 2.7% of National Vision shares are owned by insiders. Comparatively, 2.6% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better earnings and valuation, EYE or AVNS? National Vision has higher revenue and earnings than Avanos Medical. National Vision is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Vision$1.82B1.12-$28.50M-$0.18-142.78Avanos Medical$687.80M0.79-$392.10M-$10.07-1.17 SummaryNational Vision beats Avanos Medical on 12 of the 16 factors compared between the two stocks. Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVNS vs. The Competition Export to ExcelMetricAvanos MedicalMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$545.90M$7.57B$6.17B$21.98BDividend YieldN/A1.14%5.72%3.62%P/E Ratio-1.1727.3129.6632.73Price / Sales0.7927.80580.1581.53Price / Cash0.9822.2737.1224.33Price / Book0.655.2712.084.66Net Income-$392.10M$178.09M$3.32B$1.02B7 Day Performance2.26%-0.44%-0.29%1.57%1 Month Performance-1.74%1.13%5.75%0.54%1 Year Performance-47.43%2.98%65.71%12.89% Avanos Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVNSAvanos Medical2.0095 of 5 stars$11.75-0.7%N/A-47.6%$545.90M$687.80M-1.172,227News CoverageUpcoming EarningsEYENational Vision2.6668 of 5 stars$25.49-1.2%$24.73-3.0%+165.5%$2.04B$1.82B-141.6113,411Positive NewsAORTArtivion2.6971 of 5 stars$42.53+1.1%$43.97+3.4%+63.7%$1.99B$388.54M-101.271,600LMATLeMaitre Vascular3.4558 of 5 stars$88.01+1.6%$97.60+10.9%+3.2%$1.96B$219.86M42.72490LQDALiquidia Technologies3.6074 of 5 stars$24.44+8.7%$32.38+32.5%+99.5%$1.94B$14M-14.3850Analyst ForecastSSIISS Innovations InternationalN/A$9.98+2.5%N/AN/A$1.89B$20.65M0.004PRCTPROCEPT BioRobotics2.6942 of 5 stars$34.72+5.3%$67.50+94.4%-48.5%$1.83B$274.95M-22.40430Upcoming EarningsENOVEnovis3.8064 of 5 stars$32.41+3.1%$51.00+57.4%-18.2%$1.80B$2.11B-2.277,367News CoverageCDRECadre3.1777 of 5 stars$41.28+1.4%$37.50-9.2%+9.2%$1.65B$567.56M43.912,284Dividend AnnouncementNVCRNovoCure4.0023 of 5 stars$14.48+5.1%$27.50+89.9%-14.2%$1.54B$605.22M-9.281,488Upcoming EarningsCNMDCONMED4.7888 of 5 stars$47.85+5.9%$59.80+25.0%-22.5%$1.40B$1.31B13.553,900Positive News Related Companies and Tools Related Companies National Vision Competitors Artivion Competitors LeMaitre Vascular Competitors Liquidia Technologies Competitors SS Innovations International Competitors PROCEPT BioRobotics Competitors Enovis Competitors Cadre Competitors NovoCure Competitors CONMED Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AVNS) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.